Operating Expenses Summary of Maxigen Biotech Inc.

Maxigen Biotech Inc.'s latest annual operating expenses in 2023 was 274.24 Million TWD , up 13.95% from previous year.
Maxigen Biotech Inc.'s latest quarterly operating expenses in 2024 Q2 was 75.82 Million TWD , up 21.74% from previous quarter.
Maxigen Biotech Inc. reported a annual operating expenses of 240.66 Million TWD in annual operating expenses 2022, up 43.2% from previous year.
Maxigen Biotech Inc. reported a annual operating expenses of 168.05 Million TWD in annual operating expenses 2021, up 9.47% from previous year.
Maxigen Biotech Inc. reported a quarterly operating expenses of 75.82 Million TWD for 2024 Q2, up 21.74% from previous quarter.
Maxigen Biotech Inc. reported a quarterly operating expenses of 82.8 Million TWD for 2023 Q3, up 31.43% from previous quarter.

Annual Operating Expenses Chart of Maxigen Biotech Inc. (2023 - 2009)

Historical Annual Operating Expenses of Maxigen Biotech Inc. (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	274.24 Million TWD	13.95%
2022	240.66 Million TWD	43.2%
2021	168.05 Million TWD	9.47%
2020	153.51 Million TWD	1.14%
2019	151.78 Million TWD	11.25%
2018	136.43 Million TWD	-2.01%
2017	139.23 Million TWD	-4.78%
2016	146.22 Million TWD	-3.83%
2015	152.05 Million TWD	21.96%
2014	124.67 Million TWD	12.55%
2013	110.76 Million TWD	-1.31%
2012	112.23 Million TWD	21.19%
2011	92.61 Million TWD	-2.96%
2010	95.43 Million TWD	33.07%
2009	71.71 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	62.27 Million TWD	-9.95%
2024 Q2	75.82 Million TWD	21.74%
2023 Q3	82.8 Million TWD	31.43%
2023 Q1	59.27 Million TWD	-0.8%
2023 Q2	63 Million TWD	6.29%
2023 FY	274.24 Million TWD	13.95%
2023 Q4	69.16 Million TWD	-16.47%
2022 Q3	69 Million TWD	16.5%
2022 Q1	52.66 Million TWD	0.35%
2022 FY	240.66 Million TWD	43.2%
2022 Q4	59.75 Million TWD	-13.4%
2022 Q2	59.23 Million TWD	12.47%
2021 Q2	42.48 Million TWD	10.21%
2021 Q4	52.48 Million TWD	51.89%
2021 Q1	38.54 Million TWD	2.92%
2021 FY	168.05 Million TWD	9.47%
2021 Q3	34.55 Million TWD	-18.67%
2020 Q4	37.45 Million TWD	-9.94%
2020 Q1	36.42 Million TWD	-19.62%
2020 Q2	38.04 Million TWD	4.45%
2020 Q3	41.58 Million TWD	9.29%
2020 FY	153.51 Million TWD	1.14%
2019 Q4	45.31 Million TWD	29.81%
2019 Q3	34.9 Million TWD	-2.14%
2019 FY	151.78 Million TWD	11.25%
2019 Q1	35.88 Million TWD	-17.6%
2019 Q2	35.67 Million TWD	-0.58%
2018 Q3	31.42 Million TWD	-2.64%
2018 Q2	32.27 Million TWD	7.23%
2018 Q4	43.54 Million TWD	38.6%
2018 FY	136.43 Million TWD	-2.01%
2018 Q1	30.09 Million TWD	-8.18%
2017 Q2	37.33 Million TWD	8.6%
2017 FY	139.23 Million TWD	-4.78%
2017 Q3	34.75 Million TWD	-6.9%
2017 Q1	34.37 Million TWD	-6.32%
2017 Q4	32.77 Million TWD	-5.69%
2016 Q4	36.69 Million TWD	-3.89%
2016 Q2	35.64 Million TWD	-0.21%
2016 Q1	35.71 Million TWD	-14.32%
2016 Q3	38.17 Million TWD	7.12%
2016 FY	146.22 Million TWD	-3.83%
2015 Q1	34.37 Million TWD	-6.95%
2015 Q2	43.06 Million TWD	25.29%
2015 Q3	32.93 Million TWD	-23.52%
2015 Q4	41.68 Million TWD	26.57%
2015 FY	152.05 Million TWD	21.96%
2014 FY	124.67 Million TWD	12.55%
2014 Q2	29.44 Million TWD	4.06%
2014 Q1	28.29 Million TWD	-3.03%
2014 Q4	36.94 Million TWD	23.17%
2014 Q3	29.99 Million TWD	1.86%
2013 Q1	25.11 Million TWD	-19.57%
2013 Q3	26.96 Million TWD	-8.61%
2013 Q4	29.18 Million TWD	8.21%
2013 FY	110.76 Million TWD	-1.31%
2013 Q2	29.5 Million TWD	17.49%
2012 Q2	- TWD	0.0%
2012 Q4	31.22 Million TWD	5.67%
2012 Q3	29.54 Million TWD	0.0%
2012 FY	112.23 Million TWD	21.19%
2011 Q4	- TWD	0.0%
2011 FY	92.61 Million TWD	-2.96%
2011 Q2	- TWD	0.0%
2010 FY	95.43 Million TWD	33.07%
2010 Q4	- TWD	0.0%
2009 FY	71.71 Million TWD	0.0%

Peer Operating Expenses Comparison of Maxigen Biotech Inc.

Name	Operating Expenses	Operating Expenses Difference
Nang Kuang Pharmaceutical Co., Ltd.	495.65 Million TWD	44.67%
SciVision Biotech Inc.	312.85 Million TWD	12.342%
Bionime Corporation	673.63 Million TWD	59.289%
Pegavision Corporation	1.68 Billion TWD	83.745%
Visco Vision Inc.	522.44 Million TWD	47.508%

Global Stocks Search

Maxigen Biotech Inc. (1783.TW)

Operating Expenses Summary of Maxigen Biotech Inc.

Annual Operating Expenses Chart of Maxigen Biotech Inc. (2023 - 2009)

Historical Annual Operating Expenses of Maxigen Biotech Inc. (2023 - 2009)

Peer Operating Expenses Comparison of Maxigen Biotech Inc.